150 related articles for article (PubMed ID: 10334633)
41. Renoprotective effect of erdosteine in rats against gentamicin nephrotoxicity: a comparison of 99mTc-DMSA uptake with biochemical studies.
Cabuk M; Gurel A; Sen F; Demircan N
Mol Cell Biochem; 2008 Jan; 308(1-2):35-42. PubMed ID: 17899318
[TBL] [Abstract][Full Text] [Related]
42. Effects of erdosteine on hemostasis: an experimental study.
Tutanc M; Arica V; Motor S; Basarslan F; Erden ES; Ozturk OH; Zararsiz I; Aydin M
Hum Exp Toxicol; 2012 Jun; 31(6):574-8. PubMed ID: 22045892
[TBL] [Abstract][Full Text] [Related]
43. Protective effects of erdosteine on rotenone-induced oxidant injury in liver tissue.
Terzi A; Iraz M; Sahin S; Ilhan A; Idiz N; Fadillioglu E
Toxicol Ind Health; 2004 Sep; 20(6-10):141-7. PubMed ID: 15941011
[TBL] [Abstract][Full Text] [Related]
44. The effect and mechanism of action of carbocysteine on airway bacterial load in rats chronically exposed to cigarette smoke.
Sun L; Tang L; Xu Y; Wang S; Li Y; Kang J
Respirology; 2010 Oct; 15(7):1064-71. PubMed ID: 20807377
[TBL] [Abstract][Full Text] [Related]
45. In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine.
Oktem F; Arslan MK; Ozguner F; Candir O; Yilmaz HR; Ciris M; Uz E
Toxicology; 2005 Nov; 215(3):227-33. PubMed ID: 16112787
[TBL] [Abstract][Full Text] [Related]
46. The protective effect of erdosteine on short-term global brain ischemia/reperfusion injury in rats.
Ozerol E; Bilgic S; Iraz M; Cigli A; Ilhan A; Akyol O
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):20-4. PubMed ID: 18930779
[TBL] [Abstract][Full Text] [Related]
47. Erdosteine salvages cardiac necrosis: Novel effect through modulation of MAPK and Nrf-2/HO-1 pathway.
Mutneja E; Verma VK; Malik S; Sahu AK; Ray R; Bhatia J; Arya DS
J Biochem Mol Toxicol; 2020 Dec; 34(12):e22590. PubMed ID: 33210414
[TBL] [Abstract][Full Text] [Related]
48. Protective role of erdosteine pretreatment on oleic acid-induced acute lung injury.
Erdem A; Gedikli E; Yersal N; Karaismailoglu S; Muftuoglu S; Fadillioglu E; Tuncer M
J Surg Res; 2017 Jun; 213():234-242. PubMed ID: 28601320
[TBL] [Abstract][Full Text] [Related]
49. Erdosteine enhances airway response to salbutamol in patients with mild-to-moderate COPD.
Dal Negro R; Visconti M; Trevisan F; Bertacco S; Micheletto C; Tognella S
Ther Adv Respir Dis; 2008 Oct; 2(5):271-7. PubMed ID: 19124377
[TBL] [Abstract][Full Text] [Related]
50. Effects of erdosteine treatment against doxorubicin-induced toxicity through erythrocyte and plasma oxidant/antioxidant status in rats.
Fadillioğlu E; Erdoğan H
Pharmacol Res; 2003 Apr; 47(4):317-22. PubMed ID: 12644389
[TBL] [Abstract][Full Text] [Related]
51. The SH-metabolite I of erdosteine, a mucolytic drug, enhances the inhibitory effect of salbutamol on the respiratory burst of neutrophils.
Dal Sasso M; Bovio C; Culici M; Fonti E; Braga PC
Drugs Exp Clin Res; 2002; 28(4):147-54. PubMed ID: 12512232
[TBL] [Abstract][Full Text] [Related]
52. Tracheobronchial function in health and disease. Effect of mucolytic substances.
Melville GN; Ismail S; Sealy C
Respiration; 1980; 40(6):329-36. PubMed ID: 7221201
[TBL] [Abstract][Full Text] [Related]
53. Mucoactive agents for airway mucus hypersecretory diseases.
Rogers DF
Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
[TBL] [Abstract][Full Text] [Related]
54. Protective agent, erdosteine, against cisplatin-induced hepatic oxidant injury in rats.
Koc A; Duru M; Ciralik H; Akcan R; Sogut S
Mol Cell Biochem; 2005 Oct; 278(1-2):79-84. PubMed ID: 16180092
[TBL] [Abstract][Full Text] [Related]
55. Lack of gastric adverse effects of erdosteine in rats and men.
De Giovanni L; Fregnan GB; Rabitti C; Murari G; Amato A; Sovera A; Civello IM
Int J Clin Pharmacol Ther Toxicol; 1991 Jul; 29(7):269-73. PubMed ID: 1889913
[TBL] [Abstract][Full Text] [Related]
56. The protective effect of erdosteine against cyclosporine A-induced cardiotoxicity in rats.
Selcoki Y; Uz E; Bayrak R; Sahin S; Kaya A; Uz B; Karanfil A; Ozkara A; Akcay A
Toxicology; 2007 Sep; 239(1-2):53-9. PubMed ID: 17689165
[TBL] [Abstract][Full Text] [Related]
57. Protective effects of erdosteine on amikacin induced visual evoked potentials and lipid peroxidation alterations.
Derin N; Akpınar D; Ozcan F; Yargıçoğlu P; Aslan M
J Ocul Pharmacol Ther; 2011 Apr; 27(2):131-5. PubMed ID: 21323471
[TBL] [Abstract][Full Text] [Related]
58. [Bronchial clearance].
Köhler D; Vastag E
Pneumologie; 1991 May; 45(5):314-32. PubMed ID: 1857687
[No Abstract] [Full Text] [Related]
59. Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats.
Fadillioğlu E; Erdoğan H; Söğüt S; Kuku I
J Appl Toxicol; 2003; 23(1):71-4. PubMed ID: 12518339
[TBL] [Abstract][Full Text] [Related]
60. Effects of erdosteine on acetaminophen-induced hepatotoxicity in rats.
Kuvandik G; Duru M; Nacar A; Yonden Z; Helvaci R; Koc A; Kozlu T; Kaya H; Sogüt S
Toxicol Pathol; 2008 Jul; 36(5):714-9. PubMed ID: 18648099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
